Detalhe da pesquisa
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet
; 403(10442): 2416-2425, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763153
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet
; 403(10442): 2405-2415, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763154
3.
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Lancet
; 396(10260): 1413-1421, 2020 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002429
4.
Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279).
BJU Int
; 116(6): 880-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639506
5.
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.
Lancet Oncol
; 15(12): 1397-406, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25439694
6.
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
Lancet Oncol
; 15(4): 464-73, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24581940
7.
Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.
BJU Int
; 113(5): 748-53, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24053230
8.
SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer.
BJU Int
; 112(3): 330-7, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23826842
9.
Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy.
Nucl Med Commun
; 43(2): 201-211, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669678
10.
Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer.
J Contemp Brachytherapy
; 12(6): 540-546, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33437301
11.
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer.
Clin Transl Radiat Oncol
; 23: 20-26, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32368626
12.
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy.
Clin Transl Radiat Oncol
; 20: 1-8, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31701035
13.
Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial.
Int J Radiat Oncol Biol Phys
; 107(2): 316-324, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068113
14.
Folliculitis-perifolliculitis related to erlotinib therapy spares previously irradiated skin.
J Am Acad Dermatol
; 60(1): 154-7, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19103369
15.
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
Eur Urol
; 73(3): 427-435, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28705540
16.
A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer.
Radiother Oncol
; 84(2): 135-9, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17604140
17.
Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds.
Radiother Oncol
; 82(1): 46-9, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17161481
18.
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?
Nat Rev Clin Oncol
; 2017 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28895571
19.
The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer.
Radiother Oncol
; 79(2): 185-9, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16701911
20.
Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial.
Eur Urol
; 70(5): 875-883, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27344296